JP2025511145A5 - - Google Patents
Info
- Publication number
- JP2025511145A5 JP2025511145A5 JP2024557950A JP2024557950A JP2025511145A5 JP 2025511145 A5 JP2025511145 A5 JP 2025511145A5 JP 2024557950 A JP2024557950 A JP 2024557950A JP 2024557950 A JP2024557950 A JP 2024557950A JP 2025511145 A5 JP2025511145 A5 JP 2025511145A5
- Authority
- JP
- Japan
- Prior art keywords
- carrier
- solid dispersion
- pharmaceutical formulation
- pharmaceutical preparation
- preparation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2022/084214 WO2023184282A1 (en) | 2022-03-30 | 2022-03-30 | X842 formulation |
| CNPCT/CN2022/084214 | 2022-03-30 | ||
| PCT/CN2023/083375 WO2023185624A1 (en) | 2022-03-30 | 2023-03-23 | X842 formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025511145A JP2025511145A (ja) | 2025-04-15 |
| JP2025511145A5 true JP2025511145A5 (https=) | 2026-04-08 |
Family
ID=81386826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557950A Pending JP2025511145A (ja) | 2022-03-30 | 2023-03-23 | Ｘ８４２製剤 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4499046A1 (https=) |
| JP (1) | JP2025511145A (https=) |
| KR (1) | KR20240165457A (https=) |
| CN (2) | CN119139298A (https=) |
| AU (1) | AU2023247528A1 (https=) |
| MX (1) | MX2024011716A (https=) |
| WO (2) | WO2023184282A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20260019468A (ko) * | 2023-05-08 | 2026-02-10 | 싱클루스 파마 홀딩 에이비 (피유비엘) | 위식도 역류 질환(gerd) 치료를 위한 리나프라잔 글루레이트 |
| WO2026032974A1 (en) | 2024-08-05 | 2026-02-12 | Cinclus Pharma Holding AB (publ) | Formulation of linaprazan glurate |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004518709A (ja) * | 2001-02-13 | 2004-06-24 | アストラゼネカ・アクチエボラーグ | 新規放出修飾製剤 |
| US20050249799A1 (en) * | 2004-03-03 | 2005-11-10 | Spherics, Inc. | Polymeric drug delivery system for hydrophobic drugs |
| CN101513403A (zh) * | 2008-02-21 | 2009-08-26 | 上海慧德医药科技有限公司 | 含有苯并咪唑类化合物的药物制剂 |
| FI20086158A0 (fi) * | 2008-12-03 | 2008-12-03 | Mikael Dahlstroem | Imidatsopyridiinijohdannaiset |
| CN103301066B (zh) * | 2012-03-15 | 2018-12-07 | 苏州泽璟生物制药有限公司 | 一种改善吸收性能的固体分散体及其制备 |
| CN106279151A (zh) * | 2015-06-26 | 2017-01-04 | 江苏太瑞生诺生物医药科技有限公司 | 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法 |
| WO2018026764A1 (en) * | 2016-08-01 | 2018-02-08 | University Of Rochester | Nanoparticles for controlled release of anti-biofilm agents and methods of use |
| WO2020101860A1 (en) | 2018-11-16 | 2020-05-22 | Cnh Industrial America Llc | System and method for aligning arms of an agricultural header |
| CN114901262A (zh) * | 2019-11-04 | 2022-08-12 | 辛克鲁斯制药控股有限公司 | X842的口服制剂 |
| WO2021152623A1 (en) * | 2020-01-27 | 2021-08-05 | Dr. Reddy’S Laboratories Limited | Improved processes for the preparation of tafamidis and its meglumine salt |
| US20220002297A1 (en) | 2020-07-02 | 2022-01-06 | Cinclus Pharma Ag | Polymorphs of x842 |
-
2022
- 2022-03-30 WO PCT/CN2022/084214 patent/WO2023184282A1/en not_active Ceased
-
2023
- 2023-03-23 JP JP2024557950A patent/JP2025511145A/ja active Pending
- 2023-03-23 CN CN202411410163.7A patent/CN119139298A/zh active Pending
- 2023-03-23 EP EP23719627.4A patent/EP4499046A1/en active Pending
- 2023-03-23 WO PCT/CN2023/083375 patent/WO2023185624A1/en not_active Ceased
- 2023-03-23 CN CN202380010889.9A patent/CN117157059B/zh active Active
- 2023-03-23 AU AU2023247528A patent/AU2023247528A1/en active Pending
- 2023-03-23 KR KR1020247035992A patent/KR20240165457A/ko active Pending
-
2024
- 2024-09-24 MX MX2024011716A patent/MX2024011716A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2977953T3 (es) | Comprimido | |
| JP2025511145A5 (https=) | ||
| JP2005526043A5 (https=) | ||
| JP2013199488A5 (https=) | ||
| SK285300B6 (sk) | Farmaceutická formulácia obsahujúca množinu liekových podjednotiek a spôsob jej výroby | |
| JP2006502156A (ja) | 風味を遮断された投与形態およびそれらの製剤の方法 | |
| CA2686094A1 (en) | Manufacturing method of a semiconductor element | |
| KR20090029830A (ko) | 소장 내에서 활성성분의 방출이 제어되는 경구투여용 약제학적 조제물 및 그의 제조방법 | |
| FR2940619A1 (fr) | Composition comprenant un actif de solubilite aqueuse faible ou moyenne | |
| RU2015107517A (ru) | Фармацевтические композиции мемантина | |
| US20250295596A1 (en) | Multiparticulate oral dosage form providing prolonged release of tapentadol | |
| PT1711169E (pt) | Minicomprimidos revestidos de libertação prolongada de cloridrato de venlafaxina. | |
| ES2524261T3 (es) | Formulación farmacéutica sólida | |
| US20110274754A1 (en) | Oral tablet compositions of dexlansoprazole | |
| CH650922A5 (fr) | Forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette forme. | |
| CA2906378C (en) | Controlled release pharmaceutical dosage forms | |
| WO2013054352A1 (en) | Pharmaceutical compositions of ibuprofen and famotidine | |
| CN111902161A (zh) | 含达比加群酯的药物组合物及其制备方法 | |
| CA2685214C (en) | Improved controlled release oral dosage form | |
| TR201918013A2 (tr) | Propi̇veri̇n veya propi̇veri̇ni̇n farmasöti̇k olarak kabul edi̇lebi̇li̇r bi̇r tuzunu i̇çeren pellet kompozi̇syonu | |
| WO2011064743A1 (fr) | Polymere de type acrylique ou methacrylique comprenant des greffons alpha-tocopherol | |
| TR201801650T1 (tr) | Kontrollü salim propi̇veri̇n formülasyonlari | |
| EP2808019B1 (en) | Improved nitazoxanide composition and preparation method thereof | |
| NO875121L (no) | Medikamenteringsform. | |
| EP2221049A2 (en) | Solid pharmaceutical composition of ded anosine |